A Saudi medical technology company at the intersection of research, innovation, and practical application — dedicated to advancing regenerative wound care.
Arabia BioSystems is a biotechnology and medical solutions company operating at the intersection of research, innovation, and practical application. We supply cutting-edge medical and technological equipment, and deliver expert consultancy across healthcare and biotechnology — serving as a trusted end-to-end partner for both government health authorities and private sector organizations.
Everything we do is guided by a commitment to raising the standard of science and healthcare in the region. From developing tailored biotechnology products to supporting complex research initiatives, we bring the expertise, infrastructure, and strategic mindset needed to turn scientific potential into real-world impact.
To become the leading provider of advanced biologic wound-healing solutions in Saudi Arabia and the Middle East — dedicated to saving limbs, reducing amputations, and improving quality of life for patients suffering from diabetic foot ulcers, gangrene, and chronic wounds.
Arabia BioSystems is committed to delivering innovative and clinically proven biologic therapies. Through strategic partnerships with global medical manufacturers and full compliance with Saudi regulatory standards, we introduce advanced regenerative technologies to the Kingdom and support healthcare providers in achieving better patient outcomes.
Five principles that guide every decision, partnership, and product we bring to market.
We prioritize patient outcomes above all — focusing on therapies that promote faster healing, limb preservation, and improved quality of life.
We collaborate with global biotechnology leaders to bring the latest regenerative medicine technologies to Saudi Arabia and the wider region.
We operate under strict adherence to international medical standards and Saudi regulatory requirements, with no compromise.
We conduct business with full transparency, professionalism, and a commitment to building long-term partnerships founded on trust.
Our ultimate goal is to reduce amputations caused by diabetic foot ulcers and meaningfully improve healthcare outcomes across the region.
Arabia BioSystems is not just building a company — we are building the infrastructure for a healthier and scientifically empowered future in Saudi Arabia.